Reply to M.C. Chamberlain.
Publication
, Journal Article
Rubenstein, JL; Cheson, BD; Jung, S-H; Kaplan, LD
Published in: J Clin Oncol
March 10, 2014
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
March 10, 2014
Volume
32
Issue
8
Start / End Page
858 / 859
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Male
- Lymphoma, Non-Hodgkin
- Immunotherapy
- Humans
- Female
- Central Nervous System Neoplasms
- Antineoplastic Combined Chemotherapy Protocols
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Rubenstein, J. L., Cheson, B. D., Jung, S.-H., & Kaplan, L. D. (2014). Reply to M.C. Chamberlain. J Clin Oncol, 32(8), 858–859. https://doi.org/10.1200/JCO.2013.53.8942
Rubenstein, James L., Bruce D. Cheson, Sin-Ho Jung, and Lawrence D. Kaplan. “Reply to M.C. Chamberlain.” J Clin Oncol 32, no. 8 (March 10, 2014): 858–59. https://doi.org/10.1200/JCO.2013.53.8942.
Rubenstein JL, Cheson BD, Jung S-H, Kaplan LD. Reply to M.C. Chamberlain. J Clin Oncol. 2014 Mar 10;32(8):858–9.
Rubenstein, James L., et al. “Reply to M.C. Chamberlain.” J Clin Oncol, vol. 32, no. 8, Mar. 2014, pp. 858–59. Pubmed, doi:10.1200/JCO.2013.53.8942.
Rubenstein JL, Cheson BD, Jung S-H, Kaplan LD. Reply to M.C. Chamberlain. J Clin Oncol. 2014 Mar 10;32(8):858–859.
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
March 10, 2014
Volume
32
Issue
8
Start / End Page
858 / 859
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Male
- Lymphoma, Non-Hodgkin
- Immunotherapy
- Humans
- Female
- Central Nervous System Neoplasms
- Antineoplastic Combined Chemotherapy Protocols
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis